Shopping Cart 0
Cart Subtotal
USD 0

Pharmaceuticals in Russia

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 350

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 700

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 1050
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase

Details

Pharmaceuticals in Russia

Summary

Pharmaceuticals in Russia industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2013-17, and forecast to 2022). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.

Key highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.

- The Russian pharmaceuticals market had total revenues of USD 23.4bn in 2017, representing a compound annual growth rate (CAGR) of 13.7% between 2013 and 2017.

- A key driver of growth in market is that the country has a high smoking population and high alcohol consumption, which has led to cardiovascular diseases and cancer being prominent ailments.

- In Russia, the pharmaceutical market is made up of two business segments: the government procurement and the commercial market. The market is largely controlled by the commercial segment, rather than government purchasing.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia

- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia

- Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance

- Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the Russia pharmaceuticals market by value in 2017?

- What will be the size of the Russia pharmaceuticals market in 2022?

- What factors are affecting the strength of competition in the Russia pharmaceuticals market?

- How has the market performed over the last five years?

- Who are the top competitiors in Russia's pharmaceuticals market?

READ MORE

Table Of Content

Scope

Table of Contents

Executive Summary 2

Market value 2

Market value forecast 2

Geography segmentation 2

Market share 2

Market rivalry 2

Market Overview 7

Market definition 7

Market analysis 7

Market Data 9

Market value 9

Market Segmentation 10

Geography segmentation 10

Market share 11

Market Outlook 12

Market value forecast 12

Five Forces Analysis 13

Summary 13

Buyer power 14

Supplier power 16

New entrants 18

Threat of substitutes 20

Degree of rivalry 21

Leading Companies 23

Bayer AG 23

Les Laboratoires Servier 27

Novartis AG 28

Sanofi SA 31

Macroeconomic Indicators 34

Country data 34

Methodology 36

Industry associations 37

Related MarketLine research 37

Appendix 38

About MarketLine 38


List Of Figure

List of Figures

Figure 1: Russia pharmaceuticals market value: USD billion, 2013-17

Figure 2: Russia pharmaceuticals market geography segmentation: % share, by value, 2017

Figure 3: Russia pharmaceuticals market share: % share, by value, 2017

Figure 4: Russia pharmaceuticals market value forecast: USD billion, 2017-22

Figure 5: Forces driving competition in the pharmaceuticals market in Russia, 2017

Figure 6: Drivers of buyer power in the pharmaceuticals market in Russia, 2017

Figure 7: Drivers of supplier power in the pharmaceuticals market in Russia, 2017

Figure 8: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Russia, 2017

Figure 9: Factors influencing the threat of substitutes in the pharmaceuticals market in Russia, 2017

Figure 10: Drivers of degree of rivalry in the pharmaceuticals market in Russia, 2017

Figure 11: Bayer AG: revenues & profitability

Figure 12: Bayer AG: assets & liabilities

Figure 13: Novartis AG: revenues & profitability

Figure 14: Novartis AG: assets & liabilities

Figure 15: Sanofi SA: revenues & profitability

Figure 16: Sanofi SA: assets & liabilities


List Of Table

List of Tables

Table 1: Russia pharmaceuticals market value: USD billion, 2013-17

Table 2: Russia pharmaceuticals market geography segmentation: USD billion, 2017

Table 3: Russia pharmaceuticals market share: % share, by value, 2017

Table 4: Russia pharmaceuticals market value forecast: USD billion, 2017-22

Table 5: Bayer AG: key facts

Table 6: Bayer AG: key financials (USD )

Table 7: Bayer AG: key financials (EUR)

Table 8: Bayer AG: key financial ratios

Table 9: Les Laboratoires Servier: key facts

Table 10: Novartis AG: key facts

Table 11: Novartis AG: key financials (USD )

Table 12: Novartis AG: key financial ratios

Table 13: Sanofi SA: key facts

Table 14: Sanofi SA: key financials (USD )

Table 15: Sanofi SA: key financials (EUR)

Table 16: Sanofi SA: key financial ratios

Table 17: Russia size of population (million), 2013-17

Table 18: Russia gdp (constant 2005 prices, USD billion), 2013-17

Table 19: Russia gdp (current prices, USD billion), 2013-17

Table 20: Russia inflation, 2013-17

Table 21: Russia consumer price index (absolute), 2013-17

Table 22: Russia exchange rate, 2013-17

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License: 
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:  
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com